A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Sign Up to like & getrecommendations! Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1335637
Abstract: Abstract Objective: To examine the efficacy and safety of the once-weekly (q.w.) dipeptidyl peptidase-4 inhibitor, omarigliptin, in patients with type 2 diabetes (T2DM) and inadequate glycemic control on metformin monotherapy. Methods: In a randomized, double-blind… read more here.
Keywords: efficacy safety; safety weekly; omarigliptin; weekly dipeptidyl ... See more keywords
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2018.24.9-a.s14
Abstract: This article provides an overview of the efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 RAs stimulate pancreatic GLP-1 receptors, which increases… read more here.
Keywords: glp ras; glp; weight; safety weekly ... See more keywords
Efficacy and Safety of Once Weekly Thyroxine as Compared to Daily Thyroxine in Managing Primary Hypothyroidism: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_789_20
Abstract: Aims: No meta-analysis is available which has holistically analyzed efficacy and safety of once weekly thyroxine (OWT) vs. standard daily therapy (SDT) with regards to managing primary hypothyroidism. We undertook this meta-analysis to address this… read more here.
Keywords: efficacy safety; thyroxine; meta analysis; safety weekly ... See more keywords